The C4EB study—Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.

Autor: Schräder, Nicholas H. B.1 (AUTHOR) n.h.b.schrader@umcg.nl, Duipmans, José C.1 (AUTHOR), Renken, Remco J.2 (AUTHOR), Sörös, Peter3,4 (AUTHOR), Vermeulen, Karin M.5 (AUTHOR), Bolling, Maria C.1 (AUTHOR), Wolff, André P.6 (AUTHOR)
Zdroj: PLoS ONE. 12/12/2022, Vol. 17 Issue 12, p1-11. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje